Showing results (311-320 of 319) with videos related to

Sort By:
Pageof 32
You have reached the last page of results.This site can display upto 319 results.
Journal of Cancer Research and Clinical Oncology|December 12, 2022
Clinical outcomes with atezolizumab plus bevacizumab or lenvatinib in patients with hepatocellular carcinoma: a multicenter real-world studyMara Persano, Margherita Rimini, Toshifumi Tada, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|March 22, 2024
Impact of body mass index on the prognosis of unresectable HCC patients receiving first-line Lenvatinib or atezolizumab plus bevacizumabMargherita Rimini, Bernardo Stefanini, Toshifumi Tada, et al.
European Journal of Cancer (Oxford, England : 1990)|December 17, 2022
Atezolizumab plus bevacizumab versus lenvatinib for unresectable hepatocellular carcinoma: a large real-life worldwide populationAndrea Casadei-Gardini, Margherita Rimini, Toshifumi Tada, et al.
JAMA Surgery|May 21, 2024
Liver Resection vs Nonsurgical Treatments for Patients With Early Multinodular Hepatocellular CarcinomaAlessandro Vitale, Pierluigi Romano, Umberto Cillo, et al.
JHEP Reports : Innovation in Hepatology|July 21, 2025
Minimally invasive hepatectomy vs. thermoablation for single small (≤3 cm) hepatocellular carcinoma: A weighted real-life national comparisonFelice Giuliante, Simone Famularo, Sara Grasselli, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|May 23, 2024
Development and Validation of a Scoring System to Predict Response to Obeticholic Acid in Primary Biliary CholangitisAntonio De Vincentis, Javier Ampuero, Francesca Terracciani, et al.
Liver Cancer|October 9, 2025
Conversion Ability of Immunotherapy in Hepatocellular Carcinoma: Insights from the International Converse StudyAlessandro Vitale, Jung Sun Kim, Giuseppe Cabibbo, et al.
JHEP Reports : Innovation in Hepatology|July 21, 2025
Long-term effectiveness, safety, and liver stiffness dynamics of PBC treatment with obeticholic acid in real-worldFrancesca Terracciani, Antonio De Vincentis, Daphne D'Amato, et al.
Nature|March 25, 2021
NASH limits anti-tumour surveillance in immunotherapy-treated HCCDominik Pfister, Nicolás Gonzalo Núñez, Roser Pinyol, et al.
Pageof 32